Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway

Non-alcoholic fatty liver disease (NAFLD) is the most burgeoning chronic liver disease worldwide whose pathogenesis is complex and controversial. Here, we investigated the impact of caveolin-1 (CAV1), a scaffolding protein of caveolae for lipid homeostasis and endocytosis, on the pathogenesis of NAF...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 2020-03, Vol.871, p.172910-172910, Article 172910
Hauptverfasser: Xue, Weiju, Wang, Jiarong, Jiang, Wei, Shi, Congjian, Wang, Xiaohong, Huang, Yan, Hu, Chengmu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 172910
container_issue
container_start_page 172910
container_title European journal of pharmacology
container_volume 871
creator Xue, Weiju
Wang, Jiarong
Jiang, Wei
Shi, Congjian
Wang, Xiaohong
Huang, Yan
Hu, Chengmu
description Non-alcoholic fatty liver disease (NAFLD) is the most burgeoning chronic liver disease worldwide whose pathogenesis is complex and controversial. Here, we investigated the impact of caveolin-1 (CAV1), a scaffolding protein of caveolae for lipid homeostasis and endocytosis, on the pathogenesis of NAFLD. CAV1 and caveolae play crucial roles in the regulation of autophagy and hepatic energy metabolism. However, it remains unclear whether CAV1 could affect hepatic lipid metabolism by regulating autophagy. In this study, results showed that the expressions of CAV1 and autophagy-related proteins (Beclin1 and LC3-II/Ⅰ) were decreased, while the level of p62 was increased in HFD (high-fat diet) fed mice liver and in A/O (alcohol and oleic acid mixture) treated L02 cells, compared to the corresponding controls. In vivo study, upregulation of CAV1 with CAV1 scaffolding domain peptides (CSD, amino acids 82–101 of caveolin-1) could alleviate lipid accumulation and promote autophagy in NAFLD mice. In vitro study, CAV1 overexpression plasmid and its small interfering RNA were cultured with A/O treated L02 cells respectively. The results also demonstrated that CAV1 reduced lipid accumulation and promoted autophagy in L02 cells. Treatment with chloroquine, an inhibitor of autophagic degradation, abrogated CAV1 plasmid-mediated alleviation of lipid accumulation. Mechanistically, the inhibition of Akt/mTOR pathway was involved in the protective role of CAV1 in autophagy induction and lipid metabolism in NAFLD. Together, these results provided novel perception into the function of CAV1 in liver through autophagy and emphasized its positive role in NAFLD. The inhibition of Akt/mTOR pathway mediated by CAV1 could activate autophagy. Autophagosomes fuse with lysosomes to form mature autolysosomes, which degrade damaged organelles to reduce lipid accumulation. [Display omitted] •CAV1 was decreased in HFD (high-fat diet) fed mice liver and in A/O (alcohol and oleic acid mixture) treated L02 cells.•Upregulation of CAV1 with CSDcould alleviate lipid accumulation and promote autophagy in NAFLD mice.•CAV1 could reduced A/O-induced lipid accumulation and promoted autophagy in L02 cells.•For the first time, the protective role of CAV1 in reducing lipid accumulation was associated with autophagy.•CAV1 regulated the autophagy induction and lipid metabolism in NAFLD through Akt/mTOR pathway.
doi_str_mv 10.1016/j.ejphar.2020.172910
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2337070556</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299920300029</els_id><sourcerecordid>2337070556</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-174971bbe6993e6307eab5e1de73975992bd20b70556cec6cc0f90061ad8ac573</originalsourceid><addsrcrecordid>eNp9kNFO2zAUhq1p0yhsbzAhX-4m7bHTxPXNpKpQQKqGhODacpzTxl0SZ7FT6NvjEtjlriwdfb_Pfz5CfjCYMmD5bD_FfVfpfsqBx5HgksEnMmELIRMQjH8mEwA2T7iU8oyce78HgEzy7Cs5S5nkuZRsQl5W-oCutm3CqK5rPFgd0NPadrak2pihGWodrGupbenv5XpzRbX3zpywkj7bUNGud40Ltt1RPQQXK-2OtDhGvrKFfZuHCunyT5g1j_cPtNOhetbHb-TLVtcev7-_F-Rpff24uk029zd3q-UmMWnOQ8LEXApWFBjrppinIFAXGbISRSpFJiUvSg6FgCzLDZrcGNhKgJzpcqFNJtIL8nP8N9b8O6APqrHeYF3rFt3gFU9TAW_xiM5H1PTO-x63qutto_ujYqBOztVejc7VybkancfY5fuGoWiw_Bf6kByBXyOA8c6DxV55Y7E1WNoeTVCls__f8Ao8T5U2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2337070556</pqid></control><display><type>article</type><title>Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Xue, Weiju ; Wang, Jiarong ; Jiang, Wei ; Shi, Congjian ; Wang, Xiaohong ; Huang, Yan ; Hu, Chengmu</creator><creatorcontrib>Xue, Weiju ; Wang, Jiarong ; Jiang, Wei ; Shi, Congjian ; Wang, Xiaohong ; Huang, Yan ; Hu, Chengmu</creatorcontrib><description>Non-alcoholic fatty liver disease (NAFLD) is the most burgeoning chronic liver disease worldwide whose pathogenesis is complex and controversial. Here, we investigated the impact of caveolin-1 (CAV1), a scaffolding protein of caveolae for lipid homeostasis and endocytosis, on the pathogenesis of NAFLD. CAV1 and caveolae play crucial roles in the regulation of autophagy and hepatic energy metabolism. However, it remains unclear whether CAV1 could affect hepatic lipid metabolism by regulating autophagy. In this study, results showed that the expressions of CAV1 and autophagy-related proteins (Beclin1 and LC3-II/Ⅰ) were decreased, while the level of p62 was increased in HFD (high-fat diet) fed mice liver and in A/O (alcohol and oleic acid mixture) treated L02 cells, compared to the corresponding controls. In vivo study, upregulation of CAV1 with CAV1 scaffolding domain peptides (CSD, amino acids 82–101 of caveolin-1) could alleviate lipid accumulation and promote autophagy in NAFLD mice. In vitro study, CAV1 overexpression plasmid and its small interfering RNA were cultured with A/O treated L02 cells respectively. The results also demonstrated that CAV1 reduced lipid accumulation and promoted autophagy in L02 cells. Treatment with chloroquine, an inhibitor of autophagic degradation, abrogated CAV1 plasmid-mediated alleviation of lipid accumulation. Mechanistically, the inhibition of Akt/mTOR pathway was involved in the protective role of CAV1 in autophagy induction and lipid metabolism in NAFLD. Together, these results provided novel perception into the function of CAV1 in liver through autophagy and emphasized its positive role in NAFLD. The inhibition of Akt/mTOR pathway mediated by CAV1 could activate autophagy. Autophagosomes fuse with lysosomes to form mature autolysosomes, which degrade damaged organelles to reduce lipid accumulation. [Display omitted] •CAV1 was decreased in HFD (high-fat diet) fed mice liver and in A/O (alcohol and oleic acid mixture) treated L02 cells.•Upregulation of CAV1 with CSDcould alleviate lipid accumulation and promote autophagy in NAFLD mice.•CAV1 could reduced A/O-induced lipid accumulation and promoted autophagy in L02 cells.•For the first time, the protective role of CAV1 in reducing lipid accumulation was associated with autophagy.•CAV1 regulated the autophagy induction and lipid metabolism in NAFLD through Akt/mTOR pathway.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2020.172910</identifier><identifier>PMID: 31926991</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Akt ; Autophagy ; CAV1 ; Mice ; mTOR ; NAFLD</subject><ispartof>European journal of pharmacology, 2020-03, Vol.871, p.172910-172910, Article 172910</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-174971bbe6993e6307eab5e1de73975992bd20b70556cec6cc0f90061ad8ac573</citedby><cites>FETCH-LOGICAL-c362t-174971bbe6993e6307eab5e1de73975992bd20b70556cec6cc0f90061ad8ac573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejphar.2020.172910$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31926991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xue, Weiju</creatorcontrib><creatorcontrib>Wang, Jiarong</creatorcontrib><creatorcontrib>Jiang, Wei</creatorcontrib><creatorcontrib>Shi, Congjian</creatorcontrib><creatorcontrib>Wang, Xiaohong</creatorcontrib><creatorcontrib>Huang, Yan</creatorcontrib><creatorcontrib>Hu, Chengmu</creatorcontrib><title>Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Non-alcoholic fatty liver disease (NAFLD) is the most burgeoning chronic liver disease worldwide whose pathogenesis is complex and controversial. Here, we investigated the impact of caveolin-1 (CAV1), a scaffolding protein of caveolae for lipid homeostasis and endocytosis, on the pathogenesis of NAFLD. CAV1 and caveolae play crucial roles in the regulation of autophagy and hepatic energy metabolism. However, it remains unclear whether CAV1 could affect hepatic lipid metabolism by regulating autophagy. In this study, results showed that the expressions of CAV1 and autophagy-related proteins (Beclin1 and LC3-II/Ⅰ) were decreased, while the level of p62 was increased in HFD (high-fat diet) fed mice liver and in A/O (alcohol and oleic acid mixture) treated L02 cells, compared to the corresponding controls. In vivo study, upregulation of CAV1 with CAV1 scaffolding domain peptides (CSD, amino acids 82–101 of caveolin-1) could alleviate lipid accumulation and promote autophagy in NAFLD mice. In vitro study, CAV1 overexpression plasmid and its small interfering RNA were cultured with A/O treated L02 cells respectively. The results also demonstrated that CAV1 reduced lipid accumulation and promoted autophagy in L02 cells. Treatment with chloroquine, an inhibitor of autophagic degradation, abrogated CAV1 plasmid-mediated alleviation of lipid accumulation. Mechanistically, the inhibition of Akt/mTOR pathway was involved in the protective role of CAV1 in autophagy induction and lipid metabolism in NAFLD. Together, these results provided novel perception into the function of CAV1 in liver through autophagy and emphasized its positive role in NAFLD. The inhibition of Akt/mTOR pathway mediated by CAV1 could activate autophagy. Autophagosomes fuse with lysosomes to form mature autolysosomes, which degrade damaged organelles to reduce lipid accumulation. [Display omitted] •CAV1 was decreased in HFD (high-fat diet) fed mice liver and in A/O (alcohol and oleic acid mixture) treated L02 cells.•Upregulation of CAV1 with CSDcould alleviate lipid accumulation and promote autophagy in NAFLD mice.•CAV1 could reduced A/O-induced lipid accumulation and promoted autophagy in L02 cells.•For the first time, the protective role of CAV1 in reducing lipid accumulation was associated with autophagy.•CAV1 regulated the autophagy induction and lipid metabolism in NAFLD through Akt/mTOR pathway.</description><subject>Akt</subject><subject>Autophagy</subject><subject>CAV1</subject><subject>Mice</subject><subject>mTOR</subject><subject>NAFLD</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kNFO2zAUhq1p0yhsbzAhX-4m7bHTxPXNpKpQQKqGhODacpzTxl0SZ7FT6NvjEtjlriwdfb_Pfz5CfjCYMmD5bD_FfVfpfsqBx5HgksEnMmELIRMQjH8mEwA2T7iU8oyce78HgEzy7Cs5S5nkuZRsQl5W-oCutm3CqK5rPFgd0NPadrak2pihGWodrGupbenv5XpzRbX3zpywkj7bUNGud40Ltt1RPQQXK-2OtDhGvrKFfZuHCunyT5g1j_cPtNOhetbHb-TLVtcev7-_F-Rpff24uk029zd3q-UmMWnOQ8LEXApWFBjrppinIFAXGbISRSpFJiUvSg6FgCzLDZrcGNhKgJzpcqFNJtIL8nP8N9b8O6APqrHeYF3rFt3gFU9TAW_xiM5H1PTO-x63qutto_ujYqBOztVejc7VybkancfY5fuGoWiw_Bf6kByBXyOA8c6DxV55Y7E1WNoeTVCls__f8Ao8T5U2</recordid><startdate>20200315</startdate><enddate>20200315</enddate><creator>Xue, Weiju</creator><creator>Wang, Jiarong</creator><creator>Jiang, Wei</creator><creator>Shi, Congjian</creator><creator>Wang, Xiaohong</creator><creator>Huang, Yan</creator><creator>Hu, Chengmu</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200315</creationdate><title>Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway</title><author>Xue, Weiju ; Wang, Jiarong ; Jiang, Wei ; Shi, Congjian ; Wang, Xiaohong ; Huang, Yan ; Hu, Chengmu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-174971bbe6993e6307eab5e1de73975992bd20b70556cec6cc0f90061ad8ac573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Akt</topic><topic>Autophagy</topic><topic>CAV1</topic><topic>Mice</topic><topic>mTOR</topic><topic>NAFLD</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xue, Weiju</creatorcontrib><creatorcontrib>Wang, Jiarong</creatorcontrib><creatorcontrib>Jiang, Wei</creatorcontrib><creatorcontrib>Shi, Congjian</creatorcontrib><creatorcontrib>Wang, Xiaohong</creatorcontrib><creatorcontrib>Huang, Yan</creatorcontrib><creatorcontrib>Hu, Chengmu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xue, Weiju</au><au>Wang, Jiarong</au><au>Jiang, Wei</au><au>Shi, Congjian</au><au>Wang, Xiaohong</au><au>Huang, Yan</au><au>Hu, Chengmu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2020-03-15</date><risdate>2020</risdate><volume>871</volume><spage>172910</spage><epage>172910</epage><pages>172910-172910</pages><artnum>172910</artnum><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>Non-alcoholic fatty liver disease (NAFLD) is the most burgeoning chronic liver disease worldwide whose pathogenesis is complex and controversial. Here, we investigated the impact of caveolin-1 (CAV1), a scaffolding protein of caveolae for lipid homeostasis and endocytosis, on the pathogenesis of NAFLD. CAV1 and caveolae play crucial roles in the regulation of autophagy and hepatic energy metabolism. However, it remains unclear whether CAV1 could affect hepatic lipid metabolism by regulating autophagy. In this study, results showed that the expressions of CAV1 and autophagy-related proteins (Beclin1 and LC3-II/Ⅰ) were decreased, while the level of p62 was increased in HFD (high-fat diet) fed mice liver and in A/O (alcohol and oleic acid mixture) treated L02 cells, compared to the corresponding controls. In vivo study, upregulation of CAV1 with CAV1 scaffolding domain peptides (CSD, amino acids 82–101 of caveolin-1) could alleviate lipid accumulation and promote autophagy in NAFLD mice. In vitro study, CAV1 overexpression plasmid and its small interfering RNA were cultured with A/O treated L02 cells respectively. The results also demonstrated that CAV1 reduced lipid accumulation and promoted autophagy in L02 cells. Treatment with chloroquine, an inhibitor of autophagic degradation, abrogated CAV1 plasmid-mediated alleviation of lipid accumulation. Mechanistically, the inhibition of Akt/mTOR pathway was involved in the protective role of CAV1 in autophagy induction and lipid metabolism in NAFLD. Together, these results provided novel perception into the function of CAV1 in liver through autophagy and emphasized its positive role in NAFLD. The inhibition of Akt/mTOR pathway mediated by CAV1 could activate autophagy. Autophagosomes fuse with lysosomes to form mature autolysosomes, which degrade damaged organelles to reduce lipid accumulation. [Display omitted] •CAV1 was decreased in HFD (high-fat diet) fed mice liver and in A/O (alcohol and oleic acid mixture) treated L02 cells.•Upregulation of CAV1 with CSDcould alleviate lipid accumulation and promote autophagy in NAFLD mice.•CAV1 could reduced A/O-induced lipid accumulation and promoted autophagy in L02 cells.•For the first time, the protective role of CAV1 in reducing lipid accumulation was associated with autophagy.•CAV1 regulated the autophagy induction and lipid metabolism in NAFLD through Akt/mTOR pathway.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31926991</pmid><doi>10.1016/j.ejphar.2020.172910</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2020-03, Vol.871, p.172910-172910, Article 172910
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_2337070556
source ScienceDirect Journals (5 years ago - present)
subjects Akt
Autophagy
CAV1
Mice
mTOR
NAFLD
title Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A57%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caveolin-1%20alleviates%20lipid%20accumulation%20in%20NAFLD%20associated%20with%20promoting%20autophagy%20by%20inhibiting%20the%20Akt/mTOR%20pathway&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Xue,%20Weiju&rft.date=2020-03-15&rft.volume=871&rft.spage=172910&rft.epage=172910&rft.pages=172910-172910&rft.artnum=172910&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/j.ejphar.2020.172910&rft_dat=%3Cproquest_cross%3E2337070556%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2337070556&rft_id=info:pmid/31926991&rft_els_id=S0014299920300029&rfr_iscdi=true